Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.390
-0.070 (-1.57%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Lifecore Biomedical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Cash & Equivalents
17.478.278.4619.090.99
Cash & Short-Term Investments
17.478.278.4619.090.99
Cash Growth
111.36%-2.33%-55.67%1826.44%-14.49%
Accounts Receivable
33.8235.6731.1529.0238.31
Receivables
33.8243.6731.1529.0238.31
Inventory
29.0932.2939.9840.8436
Prepaid Expenses
1.921.451.444.021.05
Other Current Assets
---0.940.31
Total Current Assets
82.2985.6881.0393.88116.67
Property, Plant & Equipment
122.31123.48126.36138.67124.22
Goodwill
13.8813.8813.8813.8813.88
Other Intangible Assets
4.2--4.24.2
Long-Term Deferred Charges
---1.4-
Other Long-Term Assets
9.4916.332.681.5215.73
Total Assets
232.18239.34253.96253.55274.7

Liabilities

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Accounts Payable
5.848.2216.3322.112.95
Accrued Expenses
6.258.3810.511.2915.42
Short-Term Debt
----40
Current Portion of Long-Term Debt
0.773.270.770.5898.18
Current Portion of Leases
0.550.554.131.274.37
Current Unearned Revenue
8.663.422.114.050.92
Other Current Liabilities
1.56.345.02-4.74
Total Current Liabilities
23.5730.1838.8739.29176.58
Long-Term Debt
129.79114.82113.36101.07-
Long-Term Leases
12.6112.1810.379.717.66
Long-Term Unearned Revenue
---2.94-
Long-Term Deferred Tax Liabilities
---0.380.13
Other Long-Term Liabilities
32.1434.7337.4665.072.52
Total Liabilities
198.12191.91200.06218.46186.88

Shareholders' Equity

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Common Stock
0.040.040.030.030.03
Additional Paid-In Capital
208.96206.54177.81174.28167.35
Retained Earnings
-223.2-205.24-166.52-178.54-78.97
Comprehensive Income & Other
-----0.59
Total Common Equity
-14.21.3411.32-4.2387.82
Shareholders' Equity
34.0647.4353.935.0987.82
Total Liabilities & Equity
232.18239.34253.96253.55274.7

Additional Metrics

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Total Debt
143.73130.82128.63112.62150.2
Net Cash (Debt)
-126.26-122.56-120.17-93.53-149.21
Net Cash Growth
-----
Net Cash Per Share
-3.38-3.52-3.28-3.12-5.06
Filing Date Shares Outstanding
37.4837.4130.930.5529.6
Total Common Shares Outstanding
37.4837.0330.5630.3229.51
Working Capital
58.7255.542.1654.59-59.91
Book Value Per Share
-0.380.040.37-0.142.98
Tangible Book Value
-32.28-12.55-2.57-22.3169.74
Tangible Book Value Per Share
-0.86-0.34-0.08-0.742.36
Land
3.493.743.743.743.71
Buildings
82.0263.7362.8756.7954.56
Machinery
91.4171.1970.9377.3672.55
Construction In Progress
4.5542.2339.1545.5926.89
Leasehold Improvements
---4.024.02
SEC Filings: 10-K · 10-Q